Pharmacopeia, Inc. is a clinical development stage biopharmaceutical company dedicated to discovering and developing small molecule therapeutics to address medical needs. It has a portfolio of clinical and preclinical candidates under development internally or by partners, including eight... more

Sequenom, Inc. is a genetics and molecular diagnostic company providing genetic analysis products and services and developing diagnostic tests initially targeted at non-invasive prenatal genetic disorders. The Company's genetic analysis business provides applications that translate... more

GNI is a global pharmaceutical company dedicated to the discovery, development, and commercialization of new drugs for the treatment of diseases prevalent in Asia. A pioneer in the field of systems pharmacology, GNI applies gene network analysis and other cutting-edge biotech tools to... more

Genetix was founded by Mark Reid, its current Chief Executive, in 1991 to design and manufacture equipment and consumables for use in genomic research. Genetix has evolved by developing and launching innovative products to address the increasing demand for faster genetic research... more

BioFocus is a leading drug discovery company working in partnership with major pharmaceutical and biotechnology companies. Additionally it is developing a portfolio of internal drug discovery programmes aimed at providing drug leads for partnering. The company was founded in 1997 and is... more

Cyprotex provides high quality ADME and pharmacokinetic screening with our Cloe® Screen and Cloe® Select products. We also have extensive expertise in predictive modelling within our Cloe® Predict service. Our proprietary software, Cloe® PK, uses PB-PK modelling to integrate... more

Avantium is a leading technology company specialized in advanced high-throughput R&D for applications in the energy, chemicals and pharmaceutical industries. The company's headquarters and laboratories are located in Amsterdam, in the Netherlands. Avantium's proprietary high-throughput... more

BioTrove, Inc. develops, manufactures and markets instruments and consumables for genomic analysis, high-throughput screening and molecular diagnostics. The Company’s two marketed systems include OpenArray and RapidFire. Using micro- and nano-fluidic technologies, its products increase... more

HTG is a privately held corporation. Major investors include: Merck Capital Ventures mcv_logo-2.gif Merck Capital Ventures is a subsidiary of Merck & Co., Inc. founded in November 2000. Merck Capital Ventures (MCV) actively invests in emerging businesses with interesting technology... more

TGR BioSciences Pty Ltd (TGR) is a private biotechnology company based in Adelaide, South Australia. TGR's primary business focus is on the discovery and development of scientifically proven products that can be marketed as high-value therapies in oral and gastro-intestinal health, skin... more

ProXara Biotechnology Limited is a recently-formed biotechnology company whose mission is to be a world leader in the development of novel therapeutically-relevant cell-based and in-vitro high throughput screens for drug discovery in the oncology field. The Company was founded by... more

ChanXpress, Inc. was created to provide the biopharmaceutical industry with a service to develop unique targets and novel, improved drugs for treatment of common, chronic diseases. ChanXpress markets its patented high throughput ("HT") screening platform, HTXpress, to develop novel... more